الفهرس 
ObesityOnly 14 pages are availabe for public view
 |  | from | 129 |  |  |
| | | from | 129 | | |
Abstract
Background: Endoscopic balloons have been used for years to treat obese seeking weight loss. This study evaluated the safety and effectiveness of our lifestyle modification program.
Methods: Retrospective analysis of prospectively collected data from patients who underwent intragastric balloon insertion and minigastric bypass with a multidisciplinary follow-up program. Demographic data, weight loss complications, and satisfaction rates were assessed.
Results: In total, 45 obese individuals from March 2016 to November 2016 were included. Age 18-45 years (60% females). Initial body mass index (BMI) was 35-43 kg/m2. Three early removals due to intolerance. BMI reduction ranged 15-40% at balloon removal after 6 months and 25-50% after minigastric bypass. metabolic profile was improved in all patients. 80% of patients were satisfied with the balloon and 50% with minigastric bypass.
Conclusion: The minigastric bypass resulted in significant weight loss after 6 months of surgery, with more complications. When treating obese patients with balloon insertion there was minimal complications, high safety, and significant effectiveness. The balloon was most beneficial in obese populations and can possibly prevent future bariatric surgery. Endoscopic intragastric balloon implantation is an effective and safe method of excess body mass reduction in patients with obesity even before a planned bariatric surgical procedure. Minigastric bypass surgery is also effective and more excess body mass reduction but with more complication